• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ConforMIS

edit

ConforMIS has developed the only line of personalized, partial knee resurfacing implants to treat knee osteoarthritis, one of the most common conditions facing our aging population.

ConforMIS is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.

ConforMIS transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related ‘image-to-implant’ technology platforms. Both platforms are supported by proprietary, intellectual property consisting of more than 250 patents and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems.

To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared for marketing by the US Food and Drug Administration. Certain ConforMIS implants have also received CE Marking for the European region.

Recent Milestones

edit

• 
  ConforMIS received $89M in Series E funding. (1/30/12)
  Posted 1/30/12 at 4:00am via masshightech.com
• 
  ConforMIS received $1.4M in Grant funding. (7/12/11)
  Posted 7/12/11 at 7:50am via masshightech.com
• 
  ConforMIS — has received 510k clearance from the U.S. Food and Drug Administration to commercially market its iTotal CR Knee Replacement System (2/3/11)
  Posted 2/7/11 at 5:28am via masshightech.com
• 
  ConforMIS received $50M in Series D funding. (8/10/09)
  Posted 8/11/09 at 12:52pm via onbiovc.com
• 
  ConforMIS added Phil Licari as Chief Operating Officer.
  Posted 11/9/09 at 12:15pm
• 
  ConforMIS added Jong Lee as Senior Vice President, Marketing.
  Posted 11/9/09 at 12:16pm
• 
  ConforMIS added Philipp Lang, MD, MBA as Chief Executive Officer, President, Chairman of the Board.
  Posted 11/9/09 at 12:15pm
• 
  ConforMIS added Robert Phelps as Senior Vice President, Sales.
  Posted 11/9/09 at 12:16pm
• 
  ConforMIS added Daniel Steines, MD as Senior Vice President, R&D .
  Posted 11/9/09 at 12:16pm
• 
  ConforMIS added John Slamin as Senior Vice President, Knee Implant Engineering.
  Posted 11/9/09 at 12:17pm
• 
  ConforMIS added David Cerveny, JD as Vice President, Intellectual Property & General Counsel.
  Posted 11/9/09 at 12:17pm

Videos

Screenshots

edit

Products

edit

Sources

1. ConforMIS, Inc.: Series D $50M (onbiovc.com) [edit]
2. ConforMIS scores $1.4M MassDevelopment loan (masshightech.com) [edit]
3. ConforMIS grabs $89 Million in Series E financing (masshightech.com) [edit]
ConforMIS knee replacement tech get FDA marketing nod (masshightech.com) [edit]